Hims & Hers Faces Putative Class Action Over Misleading Diet Drug Advertisements

( February 25, 2026, 1:30 PM EST) -- CHICAGO — An online provider of compounded semaglutide for weight loss misled “consumers into believing its product is just as safe and effective as Ozempic® and Wegovy®, including because it uses ‘the same active ingredient,’ which is false,” two Illinois residents allege in a putative class action filed in an Illinois federal court....

Attached Documents

Related Sections